Torlifiq Trademark Details

This mark is alive with a status of First Extension - Granted. The last case file activity for this mark occured 7 years ago on Wednesday, September 21, 2016, according to the United State Patent & Trademark Office
Word Mark Torlifiq
Status Alive 730 — First Extension - Granted

Current Owner

Genzyme Corporation of Cambridge, MA

View all trademarks for Genzyme Corporation
Other Trademarks for Genzyme Corporation
Serial Number 86756159
Status Date Wednesday, September 21, 2016
Filing Date Wednesday, September 21, 2016
Attorney Susan Upton Douglass

Correspondent

SUSAN UPTON DOUGLASS
Fross Zelnick Lehrman & Zissu P C
866 United Nations Plz
New York, NY 10017-1822

Case File Statements

Goods & Services Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Thursday, September 17, 2015
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.